Correlation Between Vericel Corp and Prelude Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and Prelude Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and Prelude Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and Prelude Therapeutics, you can compare the effects of market volatilities on Vericel Corp and Prelude Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of Prelude Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and Prelude Therapeutics.

Diversification Opportunities for Vericel Corp and Prelude Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Vericel and Prelude is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and Prelude Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prelude Therapeutics and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with Prelude Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prelude Therapeutics has no effect on the direction of Vericel Corp i.e., Vericel Corp and Prelude Therapeutics go up and down completely randomly.

Pair Corralation between Vericel Corp and Prelude Therapeutics

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.75 times more return on investment than Prelude Therapeutics. However, Vericel Corp Ord is 1.33 times less risky than Prelude Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Prelude Therapeutics is currently generating about -0.45 per unit of risk. If you would invest  4,566  in Vericel Corp Ord on August 27, 2024 and sell it today you would earn a total of  1,296  from holding Vericel Corp Ord or generate 28.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  Prelude Therapeutics

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Prelude Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prelude Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Vericel Corp and Prelude Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and Prelude Therapeutics

The main advantage of trading using opposite Vericel Corp and Prelude Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, Prelude Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prelude Therapeutics will offset losses from the drop in Prelude Therapeutics' long position.
The idea behind Vericel Corp Ord and Prelude Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world